TCDA

Tricida, Inc.CIK 1595585 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for TCDA PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for TCDA

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Bonita David P	Director, 10% Owner	25	$15.10M	$62.21M	2022-11-25
ORBIMED ADVISORS LLC	Director, 10% Owner	4	$0	$62.21M	2022-11-25
Alpern Robert J	Director	28	$0	$1.63M	2022-11-23
Venrock Healthcare Capital Partners II, L.P.	10% Owner	13	$6.76M	$3.50M	2022-10-26
Shah Nimish P	10% Owner	5	$3.64M	$0	2022-10-17
Sibling Capital Fund II-C L.P.	10% Owner	6	$0	$4.43M	2022-10-13
VHCP Co-Investment Holdings III, LLC	10% Owner	4	$7.86M	$0	2022-10-04
Venrock Healthcare Capital Partners EG, L.P.	10% Owner	2	$4.70M	$0	2022-10-03
Sibling Capital Fund II-A L.P.	10% Owner	6	$0	$1.84M	2022-10-03
Koh Bong Y	10% Owner	6	$8.85M	$0	2022-09-07
Sibling Capital Fund II-B L.P.	10% Owner	9	$0	$3.85M	2022-08-16
Yoshiyama Annie	VP, Finance and CAO	15	$0	$0	2022-08-05
VHCP Co-Investment Holdings II, LLC	10% Owner	3	$687.2K	$0	2022-07-25
VHCP Management II, LLC	10% Owner	15	$14.15M	$0	2022-06-30
VHCP Management EG, LLC	10% Owner	1	$57.7K	$0	2022-06-16
COUFAL SANDRA I	Director, 10% Owner	74	$8.80M	$21.35M	2022-06-15
Hirsch David	Director	14	$2.50M	$0	2022-06-15
VEITINGER KLAUS R DR	Director	85	$0	$4.64M	2022-06-15
FALBERG KATHRYN E	Director	10	$600.0K	$0	2022-06-15
Sibling Capital Ventures III LLC	10% Owner	20	$8.80M	$502.1K	2022-04-28
McKague Robert	EVP, General Counsel	7	$76.2K	$0	2022-02-28
Otto Dawn Parsell	Sr VP, Clinical Development	134	$0	$2.81M	2022-02-28
KLAERNER GERRIT	President and CEO	89	$300.0K	$10.58M	2022-02-28
Parker Geoffrey M.	Chief Fin. Officer and Sr. VP	26	$4.25M	$0	2022-02-28
Stahl Wilhelm	EVP, Chief Tech Officer	73	$250.0K	$1.48M	2021-12-31
OrbiMed Capital GP V LLC	Director, 10% Owner	12	$15.10M	$0	2021-11-15
Cobo Marc	SVP, Finance & CAO	2	$0	$0	2020-09-10
Cantrell Susannah	Sr. VP, Chief Comm. Officer	4	$0	$0	2020-09-10
HEJLEK EDWARD J	SVP, General Counsel & Secy.	23	$250.0K	$1.62M	2020-03-02
Pietzke Steffen	VP Fin & Chief Acct Officer	4	$200.0K	$0	2020-02-24
Isern Brian M.	10% Owner	3	$0	$7.42M	2019-11-22
Sibling Capital Ventures II LLC	Other	7	$0	$12.24M	2019-11-21
Lockey Claire	Chief Dev. Officer and Sr. VP	48	$0	$5.74M	2019-11-01
VAN BEEK JEROEN B	Chief Comm Officer and Sr VP	1	$100.0K	$0	2018-07-02
Hadley Harbor Master Investors (Cayman) II L.P.	10% Owner	2	$0	$0	2018-07-02
Longitude Venture Partners II, L.P.	10% Owner	5	$2.50M	$0	2018-07-02

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Bonita David P	Director, 10% Owner	S Sale	2022-11-25	2022-11-25	3,629,226	$0.22	$798.4K	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	S Sale	2022-11-25	2022-11-25	3,629,226	$0.22	$798.4K	0	SEC↗
Alpern Robert J	Director	S Sale	2022-11-23	2022-11-25	131,879	$0.21	$27.7K	0	SEC↗
Bonita David P	Director, 10% Owner	S Sale	2022-11-23	2022-11-25	5,617,300	$0.21	$1.18M	3,629,226	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	S Sale	2022-11-23	2022-11-25	5,617,300	$0.21	$1.18M	3,629,226	SEC↗
Bonita David P	Director, 10% Owner	S Sale	2022-11-22	2022-11-25	1,034,421	$0.22	$227.6K	9,246,526	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	S Sale	2022-11-22	2022-11-25	1,034,421	$0.22	$227.6K	9,246,526	SEC↗
Alpern Robert J	Director	S Sale	2022-11-21	2022-11-22	27,584	$0.23	$6.3K	131,879	SEC↗
Venrock Healthcare Capital Par	10% Owner	S Sale	2022-10-26	2022-10-26	2,367,174	$0.46	$1.09M	3,751,406	SEC↗
Venrock Healthcare Capital Par	10% Owner	S Sale	2022-10-25	2022-10-26	1,970,418	$0.57	$1.12M	6,118,580	SEC↗
Venrock Healthcare Capital Par	10% Owner	S Sale	2022-10-24	2022-10-26	2,113,948	$0.61	$1.29M	8,088,998	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-10-19	2022-10-20	70,100	$11.25	$788.6K	10,202,946	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-10-19	2022-10-20	241,366	$10.29	$2.48M	10,132,846	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-10-18	2022-10-20	40,400	$11.98	$484.0K	9,891,480	SEC↗
Shah Nimish P	10% Owner	P Buy	2022-10-17	2022-10-17	170,292	$11.67	$1.99M	9,851,080	SEC↗
Sibling Capital Fund II-C L.P.	10% Owner	S Sale	2022-10-13	2022-10-13	5,704	$11.99	$68.4K	1,575,195	SEC↗
Sibling Capital Fund II-C L.P.	10% Owner	S Sale	2022-10-13	2022-10-13	23,628	$11.99	$283.3K	2,223,350	SEC↗
Shah Nimish P	10% Owner	P Buy	2022-10-13	2022-10-17	4,674	$11.98	$56.0K	9,680,788	SEC↗
Sibling Capital Fund II-C L.P.	10% Owner	S Sale	2022-10-12	2022-10-13	41,277	$12.53	$517.2K	1,580,899	SEC↗
Sibling Capital Fund II-C L.P.	10% Owner	S Sale	2022-10-12	2022-10-13	171,006	$12.53	$2.14M	2,246,978	SEC↗
Shah Nimish P	10% Owner	P Buy	2022-10-11	2022-10-11	25,000	$11.85	$296.3K	9,676,114	SEC↗
Sibling Capital Fund II-C L.P.	10% Owner	S Sale	2022-10-11	2022-10-13	23,019	$12.01	$276.5K	1,622,176	SEC↗
Sibling Capital Fund II-C L.P.	10% Owner	S Sale	2022-10-11	2022-10-13	95,366	$12.01	$1.15M	2,417,984	SEC↗
Shah Nimish P	10% Owner	P Buy	2022-10-10	2022-10-11	80,314	$11.89	$954.9K	9,651,114	SEC↗
Shah Nimish P	10% Owner	P Buy	2022-10-07	2022-10-11	28,900	$12.00	$346.8K	9,570,800	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-10-04	2022-10-06	223,100	$11.81	$2.63M	9,541,900	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-10-03	2022-10-03	268,736	$11.27	$3.03M	9,318,800	SEC↗
Sibling Capital Fund II-A L.P.	10% Owner	S Sale	2022-10-03	2022-10-04	10,349	$11.16	$115.5K	702,411	SEC↗
Sibling Capital Fund II-A L.P.	10% Owner	S Sale	2022-10-03	2022-10-04	35,877	$11.16	$400.4K	2,513,351	SEC↗
Sibling Capital Fund II-A L.P.	10% Owner	S Sale	2022-10-03	2022-10-04	22,768	$11.16	$254.1K	1,645,194	SEC↗
Sibling Capital Fund II-A L.P.	10% Owner	S Sale	2022-09-30	2022-10-04	14,995	$10.67	$160.0K	712,760	SEC↗
Sibling Capital Fund II-A L.P.	10% Owner	S Sale	2022-09-30	2022-10-04	51,983	$10.67	$554.7K	2,549,228	SEC↗
Sibling Capital Fund II-A L.P.	10% Owner	S Sale	2022-09-30	2022-10-04	32,990	$10.67	$352.0K	1,667,962	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-09-29	2022-10-03	168,187	$9.92	$1.67M	9,050,064	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-09-28	2022-09-28	76,600	$9.92	$759.9K	8,881,877	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-09-27	2022-09-28	115,000	$9.38	$1.08M	8,805,277	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-09-26	2022-09-28	395,614	$8.56	$3.39M	8,690,277	SEC↗
Koh Bong Y	10% Owner	P Buy	2022-09-07	2022-09-07	473,459	$11.40	$5.40M	8,294,663	SEC↗
Koh Bong Y	10% Owner	P Buy	2022-09-06	2022-09-07	150,223	$11.43	$1.72M	7,821,204	SEC↗
Koh Bong Y	10% Owner	P Buy	2022-09-02	2022-09-07	63,030	$12.76	$804.3K	7,670,981	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-08-30	2022-09-01	50,000	$12.20	$610.0K	7,607,951	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-16	2022-08-16	17,056	$13.59	$231.8K	2,601,211	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-16	2022-08-16	4,920	$13.59	$66.9K	727,755	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-16	2022-08-16	10,824	$13.59	$147.1K	1,700,952	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-15	2022-08-16	19,416	$13.42	$260.6K	2,618,267	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-15	2022-08-16	12,322	$13.42	$165.4K	1,711,776	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-15	2022-08-16	5,601	$13.42	$75.2K	732,675	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-12	2022-08-16	70,884	$13.50	$956.9K	1,724,098	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-12	2022-08-16	111,696	$13.50	$1.51M	2,637,683	SEC↗
Sibling Capital Fund II-B L.P.	10% Owner	S Sale	2022-08-12	2022-08-16	32,220	$13.50	$435.0K	738,276	SEC↗
Yoshiyama Annie	Senior VP, Finance and CAO	A Award deriv	2022-08-05	2022-08-09	14,000	—	$0	14,000	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-07-29	2022-08-02	18,900	$9.21	$174.1K	7,557,951	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-07-25	2022-07-25	29,199	$8.95	$261.3K	7,539,051	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-07-22	2022-07-25	15,000	$9.21	$138.2K	7,509,852	SEC↗
VHCP Co-Investment Holdings II	10% Owner	P Buy	2022-07-21	2022-07-25	30,000	$9.59	$287.7K	7,494,852	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-07-20	2022-07-20	25,000	$9.54	$238.5K	7,464,852	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-07-19	2022-07-20	25,000	$9.47	$236.8K	7,439,852	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-07-18	2022-07-20	100,000	$9.02	$902.0K	7,414,852	SEC↗
Koh Bong Y	10% Owner	P Buy	2022-07-14	2022-07-14	36,717	$9.85	$361.7K	7,314,852	SEC↗
Koh Bong Y	10% Owner	P Buy	2022-07-13	2022-07-14	32,856	$9.98	$327.9K	7,278,135	SEC↗
Koh Bong Y	10% Owner	P Buy	2022-07-12	2022-07-14	25,000	$9.81	$245.3K	7,245,279	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-07-05	2022-07-06	32,500	$9.53	$309.7K	7,220,279	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2022-07-01	2022-07-06	55,700	$9.65	$537.5K	7,187,779	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-30	2022-06-30	11,958	$9.66	$115.5K	7,132,079	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-29	2022-06-30	16,546	$9.93	$164.3K	7,120,121	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-28	2022-06-30	34,366	$9.71	$333.7K	7,103,575	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-24	2022-06-24	149,120	$9.68	$1.44M	7,069,209	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-23	2022-06-24	200,000	$10.50	$2.10M	6,920,089	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-22	2022-06-24	142,900	$10.90	$1.56M	6,720,089	SEC↗
VHCP Management EG, LLC	10% Owner	P Buy	2022-06-16	2022-06-21	5,951	$9.69	$57.7K	6,577,189	SEC↗
FALBERG KATHRYN E	Director	A Award deriv	2022-06-15	2022-06-16	27,207	—	$0	27,207	SEC↗
VEITINGER KLAUS R DR	Director	A Award deriv	2022-06-15	2022-06-16	27,207	—	$0	27,207	SEC↗
Bonita David P	Director, 10% Owner	A Award deriv	2022-06-15	2022-06-16	27,207	—	$0	27,207	SEC↗
Hirsch David	Director	A Award deriv	2022-06-15	2022-06-16	27,207	—	$0	27,207	SEC↗
Alpern Robert J	Director	A Award deriv	2022-06-15	2022-06-16	27,207	—	$0	27,207	SEC↗
COUFAL SANDRA I	Director, 10% Owner	A Award deriv	2022-06-15	2022-06-16	27,207	—	$0	27,207	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-14	2022-06-14	10,000	$8.72	$87.2K	6,571,238	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-13	2022-06-14	50,000	$8.14	$407.0K	6,561,238	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-10	2022-06-14	58,054	$8.91	$517.3K	6,511,238	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-09	2022-06-09	109,100	$8.97	$978.6K	6,453,184	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-08	2022-06-09	111,111	$9.51	$1.06M	6,344,084	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-07	2022-06-09	367,813	$9.89	$3.64M	6,232,973	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-06	2022-06-06	91,506	$9.35	$855.6K	5,865,160	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-03	2022-06-06	37,643	$9.33	$351.2K	5,773,654	SEC↗
VHCP Management II, LLC	10% Owner	P Buy	2022-06-02	2022-06-06	61,722	$8.78	$541.9K	5,736,011	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-28	2022-04-28	6,138	$10.61	$65.1K	2,749,379	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-28	2022-04-28	1,771	$10.61	$18.8K	770,496	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-28	2022-04-28	3,895	$10.61	$41.3K	1,794,982	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-27	2022-04-28	17,456	$10.97	$191.5K	2,755,517	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-27	2022-04-28	11,078	$10.97	$121.5K	1,798,877	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-27	2022-04-28	5,035	$10.97	$55.2K	772,267	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-26	2022-04-28	240	$11.90	$2.9K	1,809,955	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-26	2022-04-28	377	$11.90	$4.5K	2,772,973	SEC↗
Sibling Capital Ventures III L	10% Owner	S Sale	2022-04-26	2022-04-28	109	$11.90	$1.3K	777,302	SEC↗
COUFAL SANDRA I	Director, 10% Owner	J Other	2022-03-22	2022-03-24	463,158	—	$0	0	SEC↗
COUFAL SANDRA I	Director, 10% Owner	J Other	2022-03-22	2022-03-24	599,379	—	$0	0	SEC↗
COUFAL SANDRA I	Director, 10% Owner	J Other	2022-03-22	2022-03-24	777,411	—	$0	0	SEC↗
COUFAL SANDRA I	Director, 10% Owner	J Other	2022-03-22	2022-03-24	2,773,350	—	$0	0	SEC↗
COUFAL SANDRA I	Director, 10% Owner	J Other	2022-03-22	2022-03-24	1,810,195	—	$0	0	SEC↗
KLAERNER GERRIT	President and CEO	A Award deriv	2022-02-28	2022-03-02	511,000	—	$0	511,000	SEC↗
Parker Geoffrey M.	COO, CFO and EVP	A Award deriv	2022-02-28	2022-03-02	256,000	—	$0	256,000	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	A Award deriv	2022-02-28	2022-03-02	256,000	—	$0	256,000	SEC↗
McKague Robert	EVP, General Counsel	A Award deriv	2022-02-28	2022-03-02	256,000	—	$0	256,000	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2022-02-28	2022-03-02	86,000	—	$0	86,000	SEC↗
KLAERNER GERRIT	President and CEO	F Tax w/h	2021-12-31	2022-01-04	2,767	$9.56	$26.5K	367,390	SEC↗
Parker Geoffrey M.	COO, CFO and EVP	F Tax w/h	2021-12-31	2022-01-04	1,384	$9.56	$13.2K	63,617	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	F Tax w/h	2021-12-31	2022-01-04	1,574	$9.56	$15.0K	3,465	SEC↗
Stahl Wilhelm	EVP, Chief Tech Officer	F Tax w/h	2021-12-31	2022-01-04	1,384	$9.56	$13.2K	21,682	SEC↗
McKague Robert	EVP, General Counsel	F Tax w/h	2021-12-31	2022-01-04	1,384	$9.56	$13.2K	7,713	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-12-20	2021-12-21	7,500	$8.54	$64.0K	99,012	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-12-16	2021-12-20	931	$8.38	$7.8K	106,512	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-12-15	2021-12-17	2,550	$8.01	$20.4K	107,443	SEC↗
Stahl Wilhelm	EVP, Chief Tech Officer	A Award	2021-12-14	2021-12-16	1,664	—	$0	23,642	SEC↗
Stahl Wilhelm	EVP, Chief Tech Officer	F Tax w/h	2021-12-14	2021-12-16	576	$7.70	$4.4K	23,066	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2021-12-08	2021-12-10	8,000	$7.84	$62.7K	370,157	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-12-08	2021-12-10	500	$8.00	$4.0K	109,993	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-12-07	2021-12-09	15,722	$8.03	$126.2K	110,493	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-12-01	2021-12-03	1,600	$8.02	$12.8K	126,215	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-11-18	2021-11-22	800	$7.72	$6.2K	127,815	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-11-17	2021-11-19	10,297	$7.90	$81.3K	128,615	SEC↗
OrbiMed Capital GP V LLC	Director, 10% Owner	A Award deriv	2021-11-15	2021-11-17	666,667	—	$0	666,667	SEC↗
Bonita David P	Director, 10% Owner	A Award deriv	2021-11-15	2021-11-17	666,667	—	$0	666,667	SEC↗
Parker Geoffrey M.	COO, CFO and EVP	A Award deriv	2021-11-15	2021-11-17	166,667	—	$0	166,667	SEC↗
OrbiMed Capital GP V LLC	Director, 10% Owner	A Award	2021-11-15	2021-11-17	666,667	$6.00	$4.00M	10,280,947	SEC↗
Bonita David P	Director, 10% Owner	A Award	2021-11-15	2021-11-17	666,667	$6.00	$4.00M	10,280,947	SEC↗
Parker Geoffrey M.	COO, CFO and EVP	A Award	2021-11-15	2021-11-17	166,667	$6.00	$1.00M	261,667	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2021-11-15	2021-11-17	126,000	$6.02	$758.5K	376,493	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-10-06	2021-10-08	5,000	$4.22	$21.1K	138,912	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-09-10	2021-09-14	5,000	$4.23	$21.2K	143,912	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-08-24	2021-08-26	1,354	$4.01	$5.4K	148,912	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-08-20	2021-08-24	546	$3.87	$2.1K	150,266	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-08-19	2021-08-23	3,100	$3.96	$12.3K	150,812	SEC↗
Yoshiyama Annie	VP, Finance and CAO	D To issuer deriv	2021-08-16	2021-08-18	4,000	—	$0	0	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	3,959	—	$0	3,959	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	6,042	—	$0	6,042	SEC↗
Yoshiyama Annie	VP, Finance and CAO	D To issuer deriv	2021-08-16	2021-08-18	20,000	—	$0	0	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	2,750	—	$0	2,750	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	9,251	—	$0	9,251	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	1,600	—	$0	1,600	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	2,747	—	$0	2,747	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-08-16	2021-08-18	1,506	—	$0	1,506	SEC↗
Yoshiyama Annie	VP, Finance and CAO	D To issuer deriv	2021-08-16	2021-08-18	10,630	—	$0	0	SEC↗
Yoshiyama Annie	VP, Finance and CAO	D To issuer deriv	2021-08-16	2021-08-18	30,000	—	$0	0	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-07-20	2021-07-22	2,500	$4.02	$10.0K	153,912	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-07-15	2021-07-19	2,500	$3.76	$9.4K	156,412	SEC↗
McKague Robert	EVP, General Counsel	A Award deriv	2021-06-10	2021-06-11	125,000	—	$0	125,000	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	A Award deriv	2021-06-10	2021-06-11	125,000	—	$0	125,000	SEC↗
Alpern Robert J	Director	A Award deriv	2021-06-10	2021-06-11	57,235	—	$0	57,235	SEC↗
FALBERG KATHRYN E	Director	A Award deriv	2021-06-10	2021-06-11	57,235	—	$0	57,235	SEC↗
VEITINGER KLAUS R DR	Director	A Award deriv	2021-06-10	2021-06-11	57,235	—	$0	57,235	SEC↗
COUFAL SANDRA I	Director, 10% Owner	A Award deriv	2021-06-10	2021-06-11	57,235	—	$0	57,235	SEC↗
Bonita David P	Director, 10% Owner	A Award deriv	2021-06-10	2021-06-11	57,235	—	$0	57,235	SEC↗
Hirsch David	Director	A Award deriv	2021-06-10	2021-06-11	57,235	—	$0	57,235	SEC↗
Alpern Robert J	Director	A Award	2021-06-10	2021-06-11	16,403	—	$0	159,463	SEC↗
FALBERG KATHRYN E	Director	A Award	2021-06-10	2021-06-11	16,403	—	$0	59,163	SEC↗
VEITINGER KLAUS R DR	Director	A Award	2021-06-10	2021-06-11	16,403	—	$0	27,584	SEC↗
COUFAL SANDRA I	Director, 10% Owner	A Award	2021-06-10	2021-06-11	16,403	—	$0	158,912	SEC↗
Bonita David P	Director, 10% Owner	A Award	2021-06-10	2021-06-11	16,403	—	$0	27,584	SEC↗
Hirsch David	Director	A Award	2021-06-10	2021-06-11	16,403	—	$0	27,584	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-06-08	2021-06-10	5,000	$4.78	$23.9K	142,509	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-05-25	2021-05-27	5,000	$4.56	$22.8K	147,509	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-04-19	2021-04-21	5,000	$4.54	$22.7K	152,509	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-03-10	2021-03-12	5,000	$4.79	$23.9K	157,509	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-02-24	2021-02-26	100	$8.01	$801	162,509	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2021-02-08	2021-02-09	8,000	$7.26	$58.1K	499,993	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-02-03	2021-02-04	5,000	$6.91	$34.5K	162,609	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2021-01-26	2021-01-27	5,000	$7.06	$35.3K	167,609	SEC↗
KLAERNER GERRIT	President and CEO	A Award deriv	2021-01-17	2021-01-20	271,748	—	$0	271,748	SEC↗
Parker Geoffrey M.	CFO and EVP	A Award deriv	2021-01-17	2021-01-20	216,000	—	$0	216,000	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	A Award deriv	2021-01-17	2021-01-20	186,000	—	$0	186,000	SEC↗
McKague Robert	EVP, General Counsel	A Award deriv	2021-01-17	2021-01-20	157,500	—	$0	157,500	SEC↗
Stahl Wilhelm	EVP, Chief Tech Officer	A Award deriv	2021-01-17	2021-01-20	78,000	—	$0	78,000	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2021-01-17	2021-01-20	70,980	—	$0	70,980	SEC↗
	President and CEO	S Sale	2021-01-14	2021-01-15	1,655	$7.18	$11.9K	507,993	SEC↗
	President and CEO	S Sale	2021-01-13	2021-01-15	15,035	$7.41	$111.4K	509,648	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2021-01-12	2021-01-13	9,821	$7.65	$75.1K	524,683	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2021-01-11	2021-01-12	21,489	$7.49	$161.0K	534,504	SEC↗
COUFAL SANDRA I	Director, 10% Owner	S Sale	2020-12-14	2020-12-15	50,000	$7.90	$395.0K	172,609	SEC↗
McKague Robert	EVP, General Counsel	P Buy	2020-12-11	2020-12-23	10,000	$7.62	$76.2K	10,000	SEC↗
Parker Geoffrey M.	CFO and EVP	P Buy	2020-12-10	2020-12-10	15,000	$6.78	$101.7K	40,000	SEC↗
Yoshiyama Annie	VP, Finance and CAO	A Award deriv	2020-12-04	2020-12-08	20,000	—	$0	20,000	SEC↗
KLAERNER GERRIT	President and CEO	A Award	2020-09-10	2020-09-14	8,000	—	$0	555,993	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and EVP	A Award	2020-09-10	2020-09-14	4,000	—	$0	60,837	SEC↗
McKague Robert	EVP, General Counsel	A Award	2020-09-10	2020-09-14	4,000	—	$0	4,000	SEC↗
Cantrell Susannah	EVP, Chief Comm. Officer	A Award	2020-09-10	2020-09-14	4,000	—	$0	4,000	SEC↗
Stahl Wilhelm	EVP, Chief Tech Officer	A Award	2020-09-10	2020-09-14	4,000	—	$0	19,478	SEC↗
Cobo Marc	SVP, Finance & CAO	A Award	2020-09-10	2020-09-14	3,000	—	$0	3,000	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	A Award	2020-09-10	2020-09-14	4,000	—	$0	4,637	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-07-15	2020-07-16	4,000	$26.33	$105.3K	25,323	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-07-01	2020-07-02	4,000	$27.15	$108.6K	547,321	SEC↗
Cobo Marc	SVP, Finance & CAO	A Award deriv	2020-06-29	2020-07-01	80,000	—	$0	80,000	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-06-15	2020-06-16	1,900	$25.71	$48.8K	31,423	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-06-15	2020-06-16	2,100	$26.20	$55.0K	29,323	SEC↗
Alpern Robert J	Director	A Award deriv	2020-06-11	2020-06-15	22,967	—	$0	22,967	SEC↗
FALBERG KATHRYN E	Director	A Award deriv	2020-06-11	2020-06-15	22,967	—	$0	22,967	SEC↗
VEITINGER KLAUS R DR	Director	A Award deriv	2020-06-11	2020-06-15	22,967	—	$0	22,967	SEC↗
COUFAL SANDRA I	Director, 10% Owner	A Award deriv	2020-06-11	2020-06-15	22,967	—	$0	22,967	SEC↗
Bonita David P	Director, 10% Owner	A Award deriv	2020-06-11	2020-06-15	22,967	—	$0	22,967	SEC↗
Hirsch David	Director	A Award deriv	2020-06-11	2020-06-15	22,967	—	$0	22,967	SEC↗
Alpern Robert J	Director	A Award	2020-06-11	2020-06-15	5,670	—	$0	143,060	SEC↗
FALBERG KATHRYN E	Director	A Award	2020-06-11	2020-06-15	5,670	—	$0	42,760	SEC↗
VEITINGER KLAUS R DR	Director	A Award	2020-06-11	2020-06-15	5,670	—	$0	46,985	SEC↗
COUFAL SANDRA I	Director, 10% Owner	A Award	2020-06-11	2020-06-15	5,670	—	$0	222,609	SEC↗
Bonita David P	Director, 10% Owner	A Award	2020-06-11	2020-06-15	5,670	—	$0	11,181	SEC↗
Hirsch David	Director	A Award	2020-06-11	2020-06-15	5,670	—	$0	11,181	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-06-01	2020-06-03	4,000	$26.23	$104.9K	551,321	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-05-15	2020-05-19	2,000	$31.24	$62.5K	35,323	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-05-15	2020-05-19	2,000	$31.87	$63.7K	33,323	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and EVP	P Buy	2020-05-12	2020-05-12	1,303	$30.09	$39.2K	93,561	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and EVP	P Buy	2020-05-12	2020-05-12	1,439	$31.66	$45.6K	95,000	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and EVP	P Buy	2020-05-11	2020-05-12	12,404	$29.48	$365.7K	72,404	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and EVP	P Buy	2020-05-11	2020-05-12	19,854	$30.36	$602.8K	92,258	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-05-08	2020-05-12	1,437	—	$0	15,386	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-05-08	2020-05-12	523	—	$0	23,033	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-05-08	2020-05-12	830	—	$0	4,190	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-05-08	2020-05-12	210	—	$0	420	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-05-08	2020-05-12	523	$7.49	$3.9K	778	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-05-08	2020-05-12	1,437	$31.98	$46.0K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-05-08	2020-05-12	1,437	$2.39	$3.4K	1,692	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-05-08	2020-05-12	523	$31.98	$16.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-05-08	2020-05-12	210	$1.68	$353	465	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-05-08	2020-05-12	830	$31.98	$26.5K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-05-08	2020-05-12	830	$1.68	$1.4K	1,085	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-05-08	2020-05-12	210	$31.98	$6.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-05-05	2020-05-07	452	—	$0	16,823	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-05-05	2020-05-07	798	—	$0	5,020	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-05-05	2020-05-07	798	$30.05	$24.0K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-05-05	2020-05-07	798	$1.68	$1.3K	1,053	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-05-05	2020-05-07	452	$2.39	$1.1K	707	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-05-05	2020-05-07	452	$30.31	$13.7K	255	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-05-01	2020-05-04	3,050	$27.68	$84.4K	556,271	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-05-01	2020-05-04	100	$29.51	$3.0K	555,321	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-05-01	2020-05-04	850	$28.86	$24.5K	555,421	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-04-29	2020-04-30	210	—	$0	630	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-04-29	2020-04-30	523	—	$0	23,556	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-04-29	2020-04-30	523	—	$0	17,275	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-04-29	2020-04-30	1,744	—	$0	5,818	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-04-29	2020-04-30	1,744	$31.98	$55.8K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-04-29	2020-04-30	523	$2.39	$1.2K	778	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-04-29	2020-04-30	1,744	$1.68	$2.9K	1,999	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-04-29	2020-04-30	210	$31.98	$6.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-04-29	2020-04-30	210	$1.68	$353	465	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-04-29	2020-04-30	523	$31.98	$16.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-04-29	2020-04-30	523	$7.49	$3.9K	778	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-04-29	2020-04-30	523	$31.98	$16.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-04-28	2020-04-30	1,250	—	$0	7,562	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-04-28	2020-04-30	1,250	$1.68	$2.1K	1,505	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-04-28	2020-04-30	1,250	$29.98	$37.5K	255	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-04-15	2020-04-16	3,900	$27.46	$107.1K	37,423	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-04-15	2020-04-16	100	$27.97	$2.8K	37,323	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-04-06	2020-04-08	4,000	$24.22	$96.9K	559,321	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-03-16	2020-03-18	4,000	$23.91	$95.6K	41,323	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and EVP	P Buy	2020-03-10	2020-03-11	5,000	$29.46	$147.3K	55,000	SEC↗
McKague Robert	EVP, General Counsel	A Award deriv	2020-03-09	2020-03-11	210,000	—	$0	210,000	SEC↗
HEJLEK EDWARD J	EVP, General Counsel & Secy.	M Exercise deriv	2020-03-02	2020-03-04	10,000	—	$0	104,143	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-03-02	2020-03-04	523	—	$0	17,798	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-03-02	2020-03-04	523	—	$0	24,079	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-03-02	2020-03-04	2,994	—	$0	8,812	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise deriv	2020-03-02	2020-03-04	210	—	$0	840	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-03-02	2020-03-04	4,000	$31.53	$126.1K	563,321	SEC↗
HEJLEK EDWARD J	EVP, General Counsel & Secy.	S Sale	2020-03-02	2020-03-04	9,800	$31.65	$310.2K	19,153	SEC↗
HEJLEK EDWARD J	EVP, General Counsel & Secy.	M Exercise	2020-03-02	2020-03-04	200	$0.96	$192	19,353	SEC↗
HEJLEK EDWARD J	EVP, General Counsel & Secy.	S Sale	2020-03-02	2020-03-04	200	$32.23	$6.4K	19,153	SEC↗
HEJLEK EDWARD J	EVP, General Counsel & Secy.	M Exercise	2020-03-02	2020-03-04	9,800	$0.96	$9.4K	28,953	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-03-02	2020-03-04	2,994	$31.78	$95.1K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-03-02	2020-03-04	523	$7.49	$3.9K	778	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-03-02	2020-03-04	523	$31.98	$16.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-03-02	2020-03-04	523	$2.39	$1.2K	778	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-03-02	2020-03-04	523	$31.98	$16.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-03-02	2020-03-04	2,994	$1.68	$5.0K	3,249	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	S Sale	2020-03-02	2020-03-04	210	$31.98	$6.7K	255	SEC↗
Otto Dawn Parsell	EVP, Clinical Development	M Exercise	2020-03-02	2020-03-04	210	$1.68	$353	465	SEC↗
KLAERNER GERRIT	President and CEO	A Award deriv	2020-02-24	2020-02-26	292,000	—	$0	292,000	SEC↗
Stahl Wilhelm	Chief Tech Officer & Sr. VP	A Award deriv	2020-02-24	2020-02-26	40,000	—	$0	40,000	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	A Award deriv	2020-02-24	2020-02-26	130,000	—	$0	130,000	SEC↗
Cantrell Susannah	Sr. VP, Chief Comm. Officer	A Award deriv	2020-02-24	2020-02-26	100,000	—	$0	100,000	SEC↗
Parker Geoffrey M.	Chief Fin. Officer and Sr. V	A Award deriv	2020-02-24	2020-02-26	130,000	—	$0	130,000	SEC↗
Pietzke Steffen	VP Fin & Chief Acct Officer	A Award deriv	2020-02-24	2020-02-26	60,000	—	$0	60,000	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-02-18	2020-02-20	4,000	$36.10	$144.4K	45,323	SEC↗
Stahl Wilhelm	Chief Tech Officer & Sr. VP	M Exercise deriv	2020-02-05	2020-02-06	500	—	$0	199,942	SEC↗
Stahl Wilhelm	Chief Tech Officer & Sr. VP	S Sale	2020-02-05	2020-02-06	500	$38.91	$19.5K	14,806	SEC↗
Stahl Wilhelm	Chief Tech Officer & Sr. VP	M Exercise	2020-02-05	2020-02-06	500	$1.68	$840	15,306	SEC↗
HEJLEK EDWARD J	SVP, General Counsel & Secy.	M Exercise deriv	2020-02-03	2020-02-05	10,000	—	$0	114,143	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise deriv	2020-02-03	2020-02-05	2,994	—	$0	11,806	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise deriv	2020-02-03	2020-02-05	523	—	$0	18,321	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise deriv	2020-02-03	2020-02-05	523	—	$0	24,602	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise deriv	2020-02-03	2020-02-05	210	—	$0	1,050	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-02-03	2020-02-05	2,900	$36.58	$106.1K	567,321	SEC↗
KLAERNER GERRIT	President and CEO	S Sale	2020-02-03	2020-02-05	1,100	$35.68	$39.2K	570,221	SEC↗
HEJLEK EDWARD J	SVP, General Counsel & Secy.	S Sale	2020-02-03	2020-02-05	2,131	$35.63	$75.9K	19,153	SEC↗
HEJLEK EDWARD J	SVP, General Counsel & Secy.	M Exercise	2020-02-03	2020-02-05	7,869	$0.96	$7.6K	27,022	SEC↗
HEJLEK EDWARD J	SVP, General Counsel & Secy.	S Sale	2020-02-03	2020-02-05	7,869	$36.63	$288.2K	19,153	SEC↗
HEJLEK EDWARD J	SVP, General Counsel & Secy.	M Exercise	2020-02-03	2020-02-05	2,131	$0.96	$2.0K	21,284	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise	2020-02-03	2020-02-05	523	$2.39	$1.2K	778	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise	2020-02-03	2020-02-05	210	$1.68	$353	465	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	S Sale	2020-02-03	2020-02-05	523	$37.62	$19.7K	255	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	M Exercise	2020-02-03	2020-02-05	523	$7.49	$3.9K	778	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	S Sale	2020-02-03	2020-02-05	523	$37.31	$19.5K	255	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	S Sale	2020-02-03	2020-02-05	210	$35.58	$7.5K	255	SEC↗
Otto Dawn Parsell	Sr VP, Clinical Development	S Sale	2020-02-03	2020-02-05	400	$37.51	$15.0K	255	SEC↗